Leuzy, A., Bollack, A., Pellegrino, D., Teunissen, C. E., La Joie, R., Rabinovici, G. D., Franzmeier, N., Johnson, K., Barkhof, F., Shaw, L. M., Arkhipenko, A., Schindler, S. E., Honig, L. S., Moscoso Rial, A., Schöll, M., Zetterberg, H., Blennow, K., Hansson, O., & Farrar, G. Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer’s disease, Alzheimer's & Dementia, March 5, 2025, Read More

Ashton, N. J., Keshavan, A., Brum, W. S., Andreasson, U., Arslan, B., … Hansson, O., ... Shaw, L. M., ... Zetterberg, H. The Alzheimer’s Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study, Alzheimer's & Dementia, February 5, 2025, Read More

Xiong, C., Luo, J., Wolk, D. A., Shaw, L. M., Roberson, E. D., Murchison, C. F., Henson, R. L., Benzinger, T. L. S., Bui, Q., Agboola, F., Grant, E., Gremminger, E. N., Moulder, K. L., Geldmacher, D. S., Clay, O. J., Babulal, G., Cruchaga, C., Holtzman, D. M., Bateman, R. J., Morris, J. C., Schindler, S. E. Baseline levels and longitudinal changes in plasma Aβ42/40 among Black and white individuals, Nature Communications, July 2, 2024, Read More

Ewers, M., Franzmeier, N., Suárez-Calvet, M., Morenas-Rodriguez, E., Caballero, M. A. A., Kleinberger, G., Piccio, L., Cruchaga, C., Deming, Y., Dichgans, M., Trojanowski, J. Q., Shaw, L. M., Weiner, M. W., Haass, C., & Alzheimer’s Disease Neuroimaging Initiative Increased soluble TREM2 in cerebospinal fluid is associated with reduced cognitvie and clinical decline, Science Translational Medicine, August 28, 2019, Read More